Skip to main
LNTH
LNTH logo

Lantheus Holdings (LNTH) Stock Forecast & Price Target

Lantheus Holdings (LNTH) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Lantheus Holdings Inc is positioned for growth, particularly with the anticipated increase in market share and revenues from its POSLUMA PSMA PET imaging product, projected to rise from low to mid-single-digit share levels to high-single-digit share levels by the end of 2025. The introduction of a new Pylarify formulary, which increases batch size by approximately 50% and includes three years of TPT eligibility, is expected to rejuvenate growth in the Pylarify product line beginning in 2026. Additionally, the potential growth contributions from non-PYL segments could further enhance overall revenue and margin performance, driving better-than-expected earnings per share growth in 2026 and 2027.

Bears say

Lantheus Holdings Inc. is experiencing a decline in its growth profile, with projections for 2025-2026 indicating slower growth compared to its profitable small to mid-cap MedTech peers. The company's Pylarify product generated revenues of $260 million, reflecting an 8% year-over-year decrease and falling approximately $14 million short of consensus expectations, which has raised concerns among investors. Additionally, the lower-than-anticipated unit growth of just 2% year-over-year, coupled with a significant 10% pricing headwind, further exacerbates the negative outlook for Lantheus's financial performance.

Lantheus Holdings (LNTH) has been analyzed by 6 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Lantheus Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Lantheus Holdings (LNTH) Forecast

Analysts have given Lantheus Holdings (LNTH) a Buy based on their latest research and market trends.

According to 6 analysts, Lantheus Holdings (LNTH) has a Buy consensus rating as of Nov 27, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $74.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $74.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Lantheus Holdings (LNTH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.